Related Experiment Video
Updated: May 21, 2026
10:09
Application of Simplified Stent-bridging Pancreaticogastrostomy in Open Pancreaticoduodenectomy
Published on: March 17, 2026
Does internal stenting for pancreaticojejunostomy decrease the rate of pancreatic fistula following pancreatic
An-Ping Su1, Shuang-Shuang Cao, Yi Zhang
1Department of Hepatobiliopancreatic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Hepato-Gastroenterology
|June 13, 2012
Summary
Internal stenting for pancreaticojejunostomy (PJ) after pancreatic resections does not significantly reduce pancreatic fistula (PF) rates. This meta-analysis found no improvement in overall patient outcomes with PJ stenting.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Oncology
- Gastrointestinal Surgery
Background:
- Pancreatic fistula (PF) is a significant complication after pancreatic resections.
- Pancreaticojejunostomy (PJ) is a common surgical reconstruction method.
- Internal stenting is a technique used to reduce PF rates.
Purpose of the Study:
- To evaluate the effectiveness of internal stenting during PJ.
- To assess the impact of PJ stenting on PF formation.
- To determine the influence of PJ stenting on overall patient outcomes.
Main Methods:
- Systematic review and meta-analysis of comparative studies.
- Included articles published up to February 2012.
- Primary outcome: PF rate; Secondary outcomes: operative time, blood loss, morbidity, mortality, and hospital stay.
Main Results:
- Five studies were included in the meta-analysis.
- Internal stenting for PJ did not significantly reduce PF rates (OR 1.03; p=0.88).
- No significant differences were observed in operative time, blood loss, morbidity, mortality, or hospital stay.
Conclusions:
- Current evidence suggests internal stenting for PJ does not decrease PF rates.
- PJ stenting does not appear to alter overall patient outcomes after pancreatic resections.
